Earnings Labs
MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. (INKT)

NASDAQ·Healthcare·Biotechnology

$10.81

-3.01%

Mkt Cap $55.32M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (1 analysts)

$35.00

Range $35.00$35.00

Implied Upside

+223.9%

Consensus $35.00 vs current $10.81